Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-031851
Filing Date
2022-05-25
Accepted
2022-05-25 16:14:09
Documents
2
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2223
2 POA DOCUMENT poa.txt EX-24 3129
  Complete submission text file 0001209191-22-031851.txt   6896
Mailing Address C/O EXELIXIS INC 170 HARBOR WAY SAN FRANCISCO CA 94083
Business Address
MORRISSEY MICHAEL (Reporting) CIK: 0001202096 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40407 | Film No.: 22963048

Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Issuer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations